chr19-4792879-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018708.3(FEM1A):āc.1025C>Gā(p.Pro342Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000154 in 1,612,286 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_018708.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FEM1A | NM_018708.3 | c.1025C>G | p.Pro342Arg | missense_variant | 1/1 | ENST00000269856.5 | NP_061178.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FEM1A | ENST00000269856.5 | c.1025C>G | p.Pro342Arg | missense_variant | 1/1 | 6 | NM_018708.3 | ENSP00000269856.3 | ||
ENSG00000269604 | ENST00000601192.1 | n.2677G>C | non_coding_transcript_exon_variant | 1/2 | 4 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152132Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000104 AC: 26AN: 250424Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135692
GnomAD4 exome AF: 0.000156 AC: 228AN: 1460036Hom.: 0 Cov.: 31 AF XY: 0.000158 AC XY: 115AN XY: 726316
GnomAD4 genome AF: 0.000131 AC: 20AN: 152250Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74440
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 24, 2024 | The c.1025C>G (p.P342R) alteration is located in exon 1 (coding exon 1) of the FEM1A gene. This alteration results from a C to G substitution at nucleotide position 1025, causing the proline (P) at amino acid position 342 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at